AI ScreeningAI ChatPricing
  1. JP-listed companies
  2. CellSource Co.,Ltd.
  3. Financials
  4. Revenue growth (%)

CellSource Co.,Ltd.【JP:4880】

Market cap
¥7.5B
P/E ratio
-54.8x
CellSource processes blood and fat tissue into therapeutic substances for medical institutions offering regenerative medicine treatments like knee osteoarthritis and infertility care.
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndRevenue growth (%) YoY (%)
Oct 31, 2025-14.8+328.41%
Oct 31, 2024-3.4-162.27%
Oct 31, 20235.5-88.02%
Oct 31, 202246.3-19.55%
Oct 31, 202157.5+279.97%
Oct 31, 202015.1-54.00%
Oct 31, 201932.9-75.39%
Oct 31, 2018133.6-50.88%
Oct 31, 2017272.1

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)